Form 13-F position report

* CARDINAL HEALTH INC

Reported by CLIFFORD CAPITAL PARTNERS LLC

CAH CUSIP 14149Y108 Manager CIK 0001730467

Reported 112,249 shares, down 8,841 (7.3%) from the prior quarter.

Reported value -13.2%; share count -7.3% vs. the prior quarter.

Reduced
% of reported 13F value 3.74% This manager · Q3 2026
Shares 112,249 Quarter-end amount reported
Reported value $24,975,403 Fair value at quarter end
Consecutive quarters held 22 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 3970000
2022-03-31 6147000
2022-06-30 8886000
2022-09-30 11368000
2022-12-31 16953371
2023-03-31 16936387
2023-06-30 16236156
2023-09-30 11508599
2023-12-31 11323670
2024-03-31 12916058
2024-06-30 13767455
2024-09-30 14954903
2024-12-31 15415785
2025-03-31 17870836
2025-06-30 22477224
2025-09-30 21039860
2025-12-31 23163344
2026-03-31 24123572
2026-06-30 28766140
2026-09-30 24975403

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * CARDINAL HEALTH INC held by CLIFFORD CAPITAL PARTNERS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 112,249 -8,841 (-7.3%) 3.74% $24,975,403 2026-11-16
Q2 2026 Added 121,090 +6,928 (6.1%) 3.96% $28,766,140 2026-08-10
Q1 2026 Added 114,162 +1,445 (1.3%) 4.02% $24,123,572 2026-05-15
Q4 2025 Reduced 112,717 -21,329 (-15.9%) 3.94% $23,163,344 2026-02-17
Q3 2025 Added 134,046 +253 (0.2%) 3.64% $21,039,860 2025-11-14
Q2 2025 Added 133,793 +4,078 (3.1%) 4.29% $22,477,224 2025-08-12
Q1 2025 Reduced 129,715 -629 (-0.5%) 3.68% $17,870,836 2025-05-14
Q4 2024 Reduced 130,344 -4,970 (-3.7%) 3.2% $15,415,785 2025-02-14
Q3 2024 Reduced 135,314 -4,713 (-3.4%) 2.98% $14,954,903 2024-11-13
Q2 2024 Added 140,027 +24,602 (21.3%) 2.99% $13,767,455 2024-09-20
Q1 2024 Added 115,425 +3,087 (2.7%) 3.28% $12,916,058 2024-05-07
Q4 2023 Reduced 112,338 -20,219 (-15.3%) 2.92% $11,323,670 2024-02-14
Q3 2023 Reduced 132,557 -39,127 (-22.8%) 3.35% $11,508,599 2023-11-13
Q2 2023 Reduced 171,684 -52,639 (-23.5%) 4.7% $16,236,156 2023-08-10
Q1 2023 Added 224,323 +3,777 (1.7%) 5.21% $16,936,387 2023-05-10
Q4 2022 Added 220,546 +50,056 (29.4%) 5.15% $16,953,371 2023-02-09
Q3 2022 Added 170,490 +486 (0.3%) 4.86% $11,368,000 2022-11-08
Q2 2022 Added 170,004 +61,600 (56.8%) 3.55% $8,886,000 2022-08-08
Q1 2022 Added 108,404 +31,304 (40.6%) 3.32% $6,147,000 2022-05-05
Q4 2021 Added 77,100 +13,679 (21.6%) 2.96% $3,970,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1594 managers reported * CARDINAL HEALTH INC for Q3 2026.

Managers reporting * CARDINAL HEALTH INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 25,571,751 -918,882 0.08% $5,689,714,580 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 15,219,800 -72,386 0.07% $3,386,405,500 3 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 13,544,201 -173,693 0.14% $3,013,584,723 3 qtrs
STATE STREET CORPORATION Added 12,049,674 +82,553 0.08% $2,681,052,465 54 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 9,866,422 -4,993,849 0.39% $2,195,278,898 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 6,454,511 -18,299 0.07% $1,430,568,319 54 qtrs
MORGAN STANLEY Added 5,097,428 +472,099 0.06% $1,134,178,300 54 qtrs
Invesco Ltd Reduced 4,603,223 -139,353 0.08% $1,024,217,212 54 qtrs
JPMorgan Chase & Co Added 3,181,493 +512,744 0.04% $712,368,633 54 qtrs
Bank of America Corporation Added 2,960,829 +60,233 0.04% $658,784,307 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
75,423
Shared
0
None
36,826

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.